Phase I trial of platinum ethylenedicysteine glucosamine.

Trial Profile

Phase I trial of platinum ethylenedicysteine glucosamine.

Phase of Trial: Phase I

Latest Information Update: 19 Mar 2013

At a glance

  • Drugs Platinum ethylenedicysteine glucosamine (Primary)
  • Indications B cell lymphoma
  • Focus Adverse reactions
  • Sponsors CellPoint
  • Most Recent Events

    • 19 Mar 2013 Planned initiation is during 2013, according to CellPoint pipeline.
    • 27 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top